                         SEQUENCE LISTING

<110>  The Trustees of the University of Pennsylvania
       Riley, James L
       Ellis, Gavin
 
<120>  Methods To Protect Transplanted Tissue From Rejection

<130>  046483-7151WO1(01566)

<150>  62/477,815
<151>  2017-03-28

<160>  48    

<170>  PatentIn version 3.5

<210>  1
<211>  245
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv

<400>  1

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Val Ser Cys Ala Ala Ser Gly Val Thr Leu Ser Asp Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Ala Phe Ile Arg Asn Asp Gly Ser Asp Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Thr Val Ser 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Gly Glu Ser Gly Pro Leu Asp Tyr Trp Tyr Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Gly Gly Gly Gly Ser Gly 
        115                 120                 125             


Gly Gly Gly Ser Gly Gly Gly Gly Ser Asp Val Val Met Thr Gln Ser 
    130                 135                 140                 


Pro Ser Ser Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys 
145                 150                 155                 160 


Gln Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn Trp Tyr Gln Gln Lys 
                165                 170                 175     


Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Asp Ala Ser Asn Leu Glu 
            180                 185                 190         


Thr Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe 
        195                 200                 205             


Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr 
    210                 215                 220                 


Cys Gln Gln Tyr Ser Ser Phe Pro Leu Thr Phe Gly Gly Gly Thr Lys 
225                 230                 235                 240 


Val Asp Ile Lys Arg 
                245 


<210>  2
<211>  735
<212>  DNA
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv

<400>  2
caggtgcagc tggtgcagtc tgggggaggc gtggtccagc ctggggggtc cctgagagtc       60

tcctgtgcag cgtctggggt caccctcagt gattatggca tgcattgggt ccgccaggct      120

ccaggcaagg ggctggagtg gatggctttt atacggaatg atggaagtga taaatattat      180

gcagactccg tgaagggccg attcaccatc tccagagaca actccaagaa aacagtgtct      240

ctgcaaatga gcagtctcag agctgaagac acggctgtgt attactgtgc gaaaaatggc      300

gaatctgggc ctttggacta ctggtacttc gatctctggg gccgtggcac cctggtcacc      360

gtgtcgggtg gcggtggctc gggcggtggt gggtcgggtg gcggcggatc tgatgttgtg      420

atgactcagt ctccatcctc cctgtctgca tctgtaggag acagagtcac catcacttgc      480

caggcgagtc aggacattag caactattta aattggtatc agcagaaacc agggaaagcc      540

cctaagctcc tgatctacga tgcatccaat ttggaaacag gggtcccatc aaggttcagt      600

ggaagtggat ctgggacaga ttttactttc accatcagca gcctgcagcc tgaggatttt      660

gcaacttatt actgccaaca atatagtagt tttccgctca ctttcggcgg agggaccaaa      720

gtggatatca aacgt                                                       735


<210>  3
<211>  117
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv heavy chain (HC) variable region

<400>  3

Gln Val Gln Leu Val Gln Ser Gly Gly Gly Val Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Val Ser Cys Ala Ala Ser Gly Val Thr Leu Ser Asp Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Ala Phe Ile Arg Asn Asp Gly Ser Asp Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Lys Thr Val Ser 
65                  70                  75                  80  


Leu Gln Met Ser Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Gly Glu Ser Gly Pro Leu Asp Tyr Trp Tyr Phe Asp Leu 
            100                 105                 110         


Trp Gly Arg Gly Thr 
        115         


<210>  4
<211>  351
<212>  DNA
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv heavy chain (HC) variable region

<400>  4
caggtgcagc tggtgcagtc tgggggaggc gtggtccagc ctggggggtc cctgagagtc       60

tcctgtgcag cgtctggggt caccctcagt gattatggca tgcattgggt ccgccaggct      120

ccaggcaagg ggctggagtg gatggctttt atacggaatg atggaagtga taaatattat      180

gcagactccg tgaagggccg attcaccatc tccagagaca actccaagaa aacagtgtct      240

ctgcaaatga gcagtctcag agctgaagac acggctgtgt attactgtgc gaaaaatggc      300

gaatctgggc ctttggacta ctggtacttc gatctctggg gccgtggcac c               351


<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv HC CDR1

<400>  5

Asp Tyr Gly Met His 
1               5   


<210>  6
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv HC CDR2

<400>  6

Phe Ile Arg Asn Asp Gly Ser Asp Lys Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  7
<211>  14
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv HC CDR3

<400>  7

Asn Gly Glu Ser Gly Pro Leu Asp Tyr Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  8
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv light chain (LC) variable region

<400>  8

Asp Val Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Ser Phe Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys Arg 
            100                 105             


<210>  9
<211>  324
<212>  DNA
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv LC variable region

<400>  9
gatgttgtga tgactcagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaggattttg caacttatta ctgccaacaa tatagtagtt ttccgctcac tttcggcgga      300

gggaccaaag tggatatcaa acgt                                             324


<210>  10
<211>  11
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv LC CDR1

<400>  10

Gln Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
1               5                   10      


<210>  11
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv LC CDR2

<400>  11

Asp Ala Ser Asn Leu Glu Thr 
1               5           


<210>  12
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 scFv LC CDR3

<400>  12

Gln Gln Tyr Ser Ser Phe Pro Leu Thr 
1               5                   


<210>  13
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD8 signal peptide

<400>  13

Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro 
            20      


<210>  14
<211>  63
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD8 signal peptide

<400>  14
atggccttac cagtgaccgc cttgctcctg ccgctggcct tgctgctcca cgccgccagg       60

ccg                                                                     63


<210>  15
<211>  45
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD8 hinge

<400>  15

Thr Thr Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala 
1               5                   10                  15      


Ser Gln Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly 
            20                  25                  30          


Gly Ala Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp 
        35                  40                  45  


<210>  16
<211>  135
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD8 hinge

<400>  16
accacgacgc cagcgccgcg accaccaaca ccggcgccca ccatcgcgtc gcagcccctg       60

tccctgcgcc cagaggcgtg ccggccagcg gcggggggcg cagtgcacac gagggggctg      120

gacttcgcct gtgat                                                       135


<210>  17
<211>  27
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD28 transmembrane domain

<400>  17

Phe Trp Val Leu Val Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu 
1               5                   10                  15      


Leu Val Thr Val Ala Phe Ile Ile Phe Trp Val 
            20                  25          


<210>  18
<211>  81
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD28 transmembrane domain

<400>  18
ttttgggtgc tggtggtggt tggtggagtc ctggcttgct atagcttgct agtaacagtg       60

gcctttatta ttttctgggt g                                                 81


<210>  19
<211>  41
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD28 intracellular domain

<400>  19

Arg Ser Lys Arg Ser Arg Leu Leu His Ser Asp Tyr Met Asn Met Thr 
1               5                   10                  15      


Pro Arg Arg Pro Gly Pro Thr Arg Lys His Tyr Gln Pro Tyr Ala Pro 
            20                  25                  30          


Pro Arg Asp Phe Ala Ala Tyr Arg Ser 
        35                  40      


<210>  20
<211>  123
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD28 intracellular domain

<400>  20
aggagtaaga ggagcaggct cctgcacagt gactacatga acatgactcc ccgccgcccc       60

gggcccaccc gcaagcatta ccagccctat gccccaccac gcgacttcgc agcctatcgc      120

tcc                                                                    123


<210>  21
<211>  112
<212>  PRT
<213>  Artificial sequence

<220>
<223>  CD3 zeta domain

<400>  21

Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln Gly 
1               5                   10                  15      


Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu Tyr 
            20                  25                  30          


Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly Lys 
        35                  40                  45              


Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln Lys 
    50                  55                  60                  


Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu Arg 
65                  70                  75                  80  


Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr Ala 
                85                  90                  95      


Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro Arg 
            100                 105                 110         


<210>  22
<211>  336
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CD3 zeta domain

<400>  22
agagtgaagt tcagcaggag cgcagacgcc cccgcgtacc agcagggcca gaaccagctc       60

tataacgagc tcaatctagg acgaagagag gagtacgatg ttttggacaa gagacgtggc      120

cgggaccctg agatgggggg aaagccgaga aggaagaacc ctcaggaagg cctgtacaat      180

gaactgcaga aagataagat ggcggaggcc tacagtgaga ttgggatgaa aggcgagcgc      240

cggaggggca aggggcacga tggcctttac cagggtctca gtacagccac caaggacacc      300

tacgacgccc ttcacatgca ggccctgccc cctcgc                                336


<210>  23
<211>  497
<212>  PRT
<213>  Artificial sequence

<220>
<223>  HLA-A2 CAR

<400>  23

Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu 
1               5                   10                  15      


His Ala Ala Arg Pro Gly Ser Gln Val Gln Leu Val Gln Ser Gly Gly 
            20                  25                  30          


Gly Val Val Gln Pro Gly Gly Ser Leu Arg Val Ser Cys Ala Ala Ser 
        35                  40                  45              


Gly Val Thr Leu Ser Asp Tyr Gly Met His Trp Val Arg Gln Ala Pro 
    50                  55                  60                  


Gly Lys Gly Leu Glu Trp Met Ala Phe Ile Arg Asn Asp Gly Ser Asp 
65                  70                  75                  80  


Lys Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp 
                85                  90                  95      


Asn Ser Lys Lys Thr Val Ser Leu Gln Met Ser Ser Leu Arg Ala Glu 
            100                 105                 110         


Asp Thr Ala Val Tyr Tyr Cys Ala Lys Asn Gly Glu Ser Gly Pro Leu 
        115                 120                 125             


Asp Tyr Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val 
    130                 135                 140                 


Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
145                 150                 155                 160 


Asp Val Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
                165                 170                 175     


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            180                 185                 190         


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        195                 200                 205             


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    210                 215                 220                 


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
225                 230                 235                 240 


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Ser Ser Phe Pro Leu 
                245                 250                 255     


Thr Phe Gly Gly Gly Thr Lys Val Asp Ile Lys Arg Ser Gly Thr Thr 
            260                 265                 270         


Thr Pro Ala Pro Arg Pro Pro Thr Pro Ala Pro Thr Ile Ala Ser Gln 
        275                 280                 285             


Pro Leu Ser Leu Arg Pro Glu Ala Cys Arg Pro Ala Ala Gly Gly Ala 
    290                 295                 300                 


Val His Thr Arg Gly Leu Asp Phe Ala Cys Asp Phe Trp Val Leu Val 
305                 310                 315                 320 


Val Val Gly Gly Val Leu Ala Cys Tyr Ser Leu Leu Val Thr Val Ala 
                325                 330                 335     


Phe Ile Ile Phe Trp Val Arg Ser Lys Arg Ser Arg Leu Leu His Ser 
            340                 345                 350         


Asp Tyr Met Asn Met Thr Pro Arg Arg Pro Gly Pro Thr Arg Lys His 
        355                 360                 365             


Tyr Gln Pro Tyr Ala Pro Pro Arg Asp Phe Ala Ala Tyr Arg Ser Ile 
    370                 375                 380                 


Asp Arg Val Lys Phe Ser Arg Ser Ala Asp Ala Pro Ala Tyr Gln Gln 
385                 390                 395                 400 


Gly Gln Asn Gln Leu Tyr Asn Glu Leu Asn Leu Gly Arg Arg Glu Glu 
                405                 410                 415     


Tyr Asp Val Leu Asp Lys Arg Arg Gly Arg Asp Pro Glu Met Gly Gly 
            420                 425                 430         


Lys Pro Arg Arg Lys Asn Pro Gln Glu Gly Leu Tyr Asn Glu Leu Gln 
        435                 440                 445             


Lys Asp Lys Met Ala Glu Ala Tyr Ser Glu Ile Gly Met Lys Gly Glu 
    450                 455                 460                 


Arg Arg Arg Gly Lys Gly His Asp Gly Leu Tyr Gln Gly Leu Ser Thr 
465                 470                 475                 480 


Ala Thr Lys Asp Thr Tyr Asp Ala Leu His Met Gln Ala Leu Pro Pro 
                485                 490                 495     


Arg 
    


<210>  24
<211>  1491
<212>  DNA
<213>  Artificial sequence

<220>
<223>  HLA-A2 CAR

<400>  24
atggccttac cagtgaccgc cttgctcctg ccgctggcct tgctgctcca cgccgccagg       60

ccgggatccc aggtgcagct ggtgcagtct gggggaggcg tggtccagcc tggggggtcc      120

ctgagagtct cctgtgcagc gtctggggtc accctcagtg attatggcat gcattgggtc      180

cgccaggctc caggcaaggg gctggagtgg atggctttta tacggaatga tggaagtgat      240

aaatattatg cagactccgt gaagggccga ttcaccatct ccagagacaa ctccaagaaa      300

acagtgtctc tgcaaatgag cagtctcaga gctgaagaca cggctgtgta ttactgtgcg      360

aaaaatggcg aatctgggcc tttggactac tggtacttcg atctctgggg ccgtggcacc      420

ctggtcaccg tgtcgggtgg cggtggctcg ggcggtggtg ggtcgggtgg cggcggatct      480

gatgttgtga tgactcagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc      540

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      600

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      660

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      720

gaggattttg caacttatta ctgccaacaa tatagtagtt ttccgctcac tttcggcgga      780

gggaccaaag tggatatcaa acgttccgga accacgacgc cagcgccgcg accaccaaca      840

ccggcgccca ccatcgcgtc gcagcccctg tccctgcgcc cagaggcgtg ccggccagcg      900

gcggggggcg cagtgcacac gagggggctg gacttcgcct gtgatttttg ggtgctggtg      960

gtggttggtg gagtcctggc ttgctatagc ttgctagtaa cagtggcctt tattattttc     1020

tgggtgagga gtaagaggag caggctcctg cacagtgact acatgaacat gactccccgc     1080

cgccccgggc ccacccgcaa gcattaccag ccctatgccc caccacgcga cttcgcagcc     1140

tatcgctcca tcgatagagt gaagttcagc aggagcgcag acgcccccgc gtaccagcag     1200

ggccagaacc agctctataa cgagctcaat ctaggacgaa gagaggagta cgatgttttg     1260

gacaagagac gtggccggga ccctgagatg gggggaaagc cgagaaggaa gaaccctcag     1320

gaaggcctgt acaatgaact gcagaaagat aagatggcgg aggcctacag tgagattggg     1380

atgaaaggcg agcgccggag gggcaagggg cacgatggcc tttaccaggg tctcagtaca     1440

gccaccaagg acacctacga cgcccttcac atgcaggccc tgccccctcg c              1491


<210>  25
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker


<220>
<221>  REPEAT
<222>  (1)..(5)
<223>  Repeat n times. n is an integer of at least 1.

<400>  25

Gly Ser Gly Gly Ser 
1               5   


<210>  26
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker


<220>
<221>  REPEAT
<222>  (1)..(4)
<223>  Repeat n times. n is an integer of at least 1.

<400>  26

Gly Gly Gly Ser 
1               


<210>  27
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker


<220>
<221>  REPEAT
<222>  (1)..(5)
<223>  Repeat n times. n is an integer of at least 1.

<400>  27

Gly Gly Gly Gly Ser 
1               5   


<210>  28
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  28

Gly Gly Ser Gly 
1               


<210>  29
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  29

Gly Gly Ser Gly Gly 
1               5   


<210>  30
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  30

Gly Ser Gly Ser Gly 
1               5   


<210>  31
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  31

Gly Ser Gly Gly Gly 
1               5   


<210>  32
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  32

Gly Gly Gly Ser Gly 
1               5   


<210>  33
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  33

Gly Ser Ser Ser Gly 
1               5   


<210>  34
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  34

Gly Gly Gly Gly Ser 
1               5   


<210>  35
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  linker

<400>  35

Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10                  15  


<210>  36
<211>  45
<212>  DNA
<213>  Artificial sequence

<220>
<223>  linker

<400>  36
ggtggcggtg gctcgggcgg tggtgggtcg ggtggcggcg gatct                       45


<210>  37
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  37

Asp Lys Thr His Thr 
1               5   


<210>  38
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  38

Cys Pro Pro Cys 
1               


<210>  39
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  39

Cys Pro Glu Pro Lys Ser Cys Asp Thr Pro Pro Pro Cys Pro Arg 
1               5                   10                  15  


<210>  40
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  40

Glu Leu Lys Thr Pro Leu Gly Asp Thr Thr His Thr 
1               5                   10          


<210>  41
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  41

Lys Ser Cys Asp Lys Thr His Thr Cys Pro 
1               5                   10  


<210>  42
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  42

Lys Cys Cys Val Asp Cys Pro 
1               5           


<210>  43
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  43

Lys Tyr Gly Pro Pro Cys Pro 
1               5           


<210>  44
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  44

Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys Pro 
1               5                   10                  15  


<210>  45
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  45

Glu Arg Lys Cys Cys Val Glu Cys Pro Pro Cys Pro 
1               5                   10          


<210>  46
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  46

Glu Leu Lys Thr Pro Leu Gly Asp Thr Thr His Thr Cys Pro Arg Cys 
1               5                   10                  15      


Pro 
    


<210>  47
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  47

Ser Pro Asn Met Val Pro His Ala His His Ala Gln 
1               5                   10          


<210>  48
<211>  15
<212>  PRT
<213>  Artificial sequence

<220>
<223>  hinge

<400>  48

Glu Pro Lys Ser Cys Asp Lys Thr Tyr Thr Cys Pro Pro Cys Pro 
1               5                   10                  15  


